Moscow Scientific Research Oncology Institute P.A. Herzen

Moscow 125284

0 studies enrolling now · 2 studies all time

What they study most

Renal Cell Carcinoma

Studies at this site

• Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma — Completed
• Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects — Completed